Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass

S. Manikappa; K. Benfield; T. E. Gan; J. Butler; E. Malan; H. A.M. Tran; A. Tucker

doi:10.1177/0310057x0503300316

Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass

S. Manikappa, K. Benfield, T. E. Gan, J. Butler, E. Malan, H. A.M. Tran, A. Tucker

Research output: Contribution to journal › Article › Research › peer-review

4 Citations (Scopus)

Abstract

We report the successful use of r-hirudin (lepirudin) for cardiopulmonary bypass in a 67-year-old man who developed heparin-induced thrombocytopenia type II during heparin treatment of an extensive deep venous thrombosis. Lepirudin was monitored by the modified ecarin clotting time in a "mobile laboratory" set up next to the cardiac theatre, aiming for lepirudin levels of 3.5 to 4.5 μl/ml during bypass.

Original language	English
Pages (from-to)	388-392
Number of pages	5
Journal	Anaesthesia and Intensive Care
Volume	33
Issue number	3
DOIs	https://doi.org/10.1177/0310057x0503300316
Publication status	Published - Jun 2005
Externally published	Yes

Keywords

R-hirudin
Thrombocytopena: heparin-induced, cardiopulmonary bypass

Access to Document

10.1177/0310057x0503300316

Cite this

@article{6e164cce9a4c45e8bfe4f89eb2b81e93,

title = "Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass",

abstract = "We report the successful use of r-hirudin (lepirudin) for cardiopulmonary bypass in a 67-year-old man who developed heparin-induced thrombocytopenia type II during heparin treatment of an extensive deep venous thrombosis. Lepirudin was monitored by the modified ecarin clotting time in a {"}mobile laboratory{"} set up next to the cardiac theatre, aiming for lepirudin levels of 3.5 to 4.5 μl/ml during bypass.",

keywords = "R-hirudin, Thrombocytopena: heparin-induced, cardiopulmonary bypass",

author = "S. Manikappa and K. Benfield and Gan, \{T. E.\} and J. Butler and E. Malan and Tran, \{H. A.M.\} and A. Tucker",

year = "2005",

month = jun,

doi = "10.1177/0310057x0503300316",

language = "English",

volume = "33",

pages = "388--392",

journal = "Anaesthesia and Intensive Care",

issn = "0310-057X",

publisher = "SAGE Publications Ltd",

number = "3",

}

TY - JOUR

T1 - Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass

AU - Manikappa, S.

AU - Benfield, K.

AU - Gan, T. E.

AU - Butler, J.

AU - Malan, E.

AU - Tran, H. A.M.

AU - Tucker, A.

PY - 2005/6

Y1 - 2005/6

N2 - We report the successful use of r-hirudin (lepirudin) for cardiopulmonary bypass in a 67-year-old man who developed heparin-induced thrombocytopenia type II during heparin treatment of an extensive deep venous thrombosis. Lepirudin was monitored by the modified ecarin clotting time in a "mobile laboratory" set up next to the cardiac theatre, aiming for lepirudin levels of 3.5 to 4.5 μl/ml during bypass.

AB - We report the successful use of r-hirudin (lepirudin) for cardiopulmonary bypass in a 67-year-old man who developed heparin-induced thrombocytopenia type II during heparin treatment of an extensive deep venous thrombosis. Lepirudin was monitored by the modified ecarin clotting time in a "mobile laboratory" set up next to the cardiac theatre, aiming for lepirudin levels of 3.5 to 4.5 μl/ml during bypass.

KW - R-hirudin

KW - Thrombocytopena: heparin-induced, cardiopulmonary bypass

UR - https://www.scopus.com/pages/publications/21344465454

U2 - 10.1177/0310057x0503300316

DO - 10.1177/0310057x0503300316

M3 - Article

C2 - 15973924

AN - SCOPUS:21344465454

SN - 0310-057X

VL - 33

SP - 388

EP - 392

JO - Anaesthesia and Intensive Care

JF - Anaesthesia and Intensive Care

IS - 3

ER -

Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass

Abstract

Keywords

Access to Document

Other files and links

Cite this